Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
85,635,017
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
14,567,301
-
Shares change
-
-5,787
-
Total reported value, excl. options
-
$157,170,000
-
Value change
-
-$456,088
-
Number of buys
-
15
-
Number of sells
-
-22
-
Price
-
$10.79
Significant Holders of Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) as of Q4 2021
57 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,567,301 shares
of 85,635,017 outstanding shares and own 17.01% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5,830,249 shares), CHI Advisors LLC (1,515,148 shares), RA CAPITAL MANAGEMENT, L.P. (1,334,610 shares), Opaleye Management Inc. (883,602 shares), JANUS HENDERSON GROUP PLC (735,112 shares), VANGUARD GROUP INC (526,043 shares), Vivo Capital, LLC (399,830 shares), Atlas Venture Advisors, Inc. (292,184 shares), 683 Capital Management, LLC (256,620 shares), and BlackRock Inc. (244,897 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.